GlassScriptPhysician profile
Robert Adams Dubose
NPI 1578610374
$44,574.81
in general payments reported to CMS, 2019-2025
15 companies · $5,835 in 2025
The $5,835 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $384 · 2021: $307 · 2022: $6,485 · 2023: $10K · 2024: $4,964 · 2025: $5,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,750 · Education: $7,750 · Food and Beverage: $4,514 · Travel and Lodging: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,750.00 |
| Education | $7,750.00 |
| Food and Beverage | $4,514.34 |
| Travel and Lodging | $270.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $33,334.29 | 2019-2025 | Sternalock Blu System, Sternalock 360 System, Sternalock |
| Abbott Laboratories | $3,457.02 | 2019-2025 | Amplatzer |
| Abiomed | $3,149.10 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $2,069.69 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $1,733.48 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $469.74 | 2022-2025 | Avalus, Penditure |
| Artivion, INC. | $82.97 | 2019-2021 | |
| Ethicon US, LLC | $65.57 | 2023-2025 | Ethicon, Prolene, Stratafix |
| Shockwave Medical, INC | $61.00 | 2019 | |
| Getinge USA Sales, LLC | $44.78 | 2019-2020 | |
| Haemonetics Corporation | $29.63 | 2025 | Teg6s Hemostasis System |
| E.R. Squibb & Sons, L.L.C. | $26.66 | 2019 | |
| Chiesi USA, INC. | $19.32 | 2019 | |
| Amgen INC. | $16.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dubose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.